AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 158 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $598,000 | -27.5% | 35,800 | -37.5% | 0.00% | -50.0% |
Q1 2020 | $825,000 | -49.8% | 57,240 | +16.6% | 0.01% | -45.5% |
Q4 2019 | $1,643,000 | +248.8% | 49,100 | +118.2% | 0.01% | +175.0% |
Q3 2019 | $471,000 | -55.8% | 22,500 | -56.1% | 0.00% | -55.6% |
Q2 2019 | $1,066,000 | – | 51,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |